Stock·NYSE·Consumer Defensive
Hormel Foods Corporation (HRL)
- Market cap
- $11.53B
- P/E
- 34.34
- Dividend yield
- 5.59%
- Street target
- $25.00median of 10 analysts
- 52-week range
- $18.96 $26.60
HRL stock forecast today
Where HRL stands today, and what CleaRank Financial AI makes of it.
HRL at a glance
Hormel Foods Corporation (HRL): Hold, 45/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($21.08 and $22.88).
- Earnings HRL beat estimates in 4 of the 7 reports in our data, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $817K and bought $201K over the last 18 months.
- Valuation P/E of 34.3 against 24.2 for the Consumer Defensive sector: a premium to peers (+42%).
Figures as of October 26, 2026.
CleaRank Financial AI
Hormel Foods Corporation (HRL) carries a CleaRank rating of Hold and a model score of 45/100.
The trend subtracts the most. HRL trades 8.44% below its 200-day average and 0.61% below its 50-day, and the 50-day sits 7.88% below the 200-day. Those averages are $21.08 and $22.88. Across the past year, the price declined 12.09%.
Only on CleaRank
Figures we compute ourselves from HRL's own price, earnings and insider-filing history. Tap one to see it in context.
HRL stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $20.95 is 0.6% below the 50-day simple moving average of $21.08.Price above its 200-day average ›
The price is 8.4% below the 200-day simple moving average of $22.88.50-day average above the 200-day ›
The 50-day average ($21.08) is 7.9% below the 200-day average ($22.88), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 26% of its 52-week range, between $18.96 and $26.60.
HRL share price
Pick a period: each tab shows how far HRL has moved over it, to the last close.
Today's trading
Where HRL sits inside today's range and its 52-week range.
HRL fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 34.34 is 41.9% above the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 0.95 is 56.6% below the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $342.7M on revenue of $12.1B, a net margin of 2.8%.Beat estimates in most recent reports ›
HRL beat the EPS estimate in 4 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 5.59%, or $1.17 a share a year.
Key statistics
The headline figures for HRL.
As of October 26, 2026, HRL trades at $20.95, with a market value of $11.53B, a P/E ratio of 34.34 and a dividend yield of 5.59%.
What the numbers say
CleaRank Financial AI's reading of HRL's valuation, growth and risks.
Hormel Foods Corporation (HRL) has a trailing P/E of 34.34, which is 42.7% above the Consumer Defensive median of 24.2. The peer comparison on this page puts the P/E at a premium to peers. On sales, the price-to-sales ratio of 0.95 is 56.8% below the sector median of 2.2. HRL carries a market capitalisation of $11.5B and reported trailing earnings of $0.61 a share.
HRL trails the sector on growth: revenue shrank 2.40% in the latest quarter year on year, while the sector median is 5.3%. Its net margin stands at 2.82% and its operating margin at 8.62%. Return on equity is 4.29%, below the sector median of 19.7%. On the balance sheet, debt-to-equity is 0.36, and the trailing dividend yield is 5.59%, or $1.17 a share a year.
HRL's most recent quarterly report, released on August 27, 2026, topped the estimate by 5.71%. EPS came in at $0.37, compared with an estimate of $0.35. In the first session after the report, the share price rose 1.36%.
Analysts forecast EPS of $1.48 for this fiscal year, a rise of 8.3%, and $1.57 for the year after, a rise of 5.6%.
With a P/E of 34.34 sitting 41.9% above the sector median, HRL is priced at a premium to peers, which means weaker results would be judged against a higher bar. The average daily move is 1.41%, and the beta against the S&P 500 is 0.29. The trend is a drag on holders until the price gets back above its moving averages. At present the price is 21.24% below the 52-week high of $26.60.
HRL against the Consumer Defensive sector
How HRL compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: HRL trades at a significant premium to sector peers (+42%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 14, 2025, HRL has lost 28.2% against a gain of 30.3% for SPY.
Performance against SPY
HRL and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much HRL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 1.6% in FY2025 to $12.1B, from $11.9B a year earlier.
Profit margin: The net margin was 3.9% in FY2025, down from 6.7% the year before.
Profitable: HRL earned $478M in FY2025.
Earnings reality check
Did HRL beat what analysts expected, and how did the stock react?
Earnings record: HRL beat the analyst estimate in 4 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 1 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 27, 2026after close | $0.35 | $0.37 | +5.71% | +1.36% | +1.88% |
| May 28, 2026after close | $0.35 | $0.40 | +14.29% | -1.53% | -1.27% |
| Dec 4, 2025after close | $0.30 | $0.32 | +6.67% | +0.75% | -1.86% |
| Aug 28, 2025after close | $0.41 | $0.35 | -14.63% | +0.87% | +1.74% |
| May 29, 2025after close | $0.34 | $0.35 | +2.94% | +0.99% | +1.09% |
| Feb 27, 2025after close | $0.37 | $0.35 | -5.41% | +0.88% | +2.18% |
| Dec 4, 2024after close | $0.42 | $0.42 | +0.00% | +2.72% | +3.56% |
As of October 26, 2026, HRL has beaten the analyst EPS estimate in 4 of the 7 reports in our data and fell in the first trading session after 1 of those beats; its latest report, on August 27, 2026, came in 5.71% above the estimate and the stock moved +1.36% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
HRL AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/2RSI not overbought or oversold ›
The 14-day RSI is 56.7, in neutral territory.RSI above 50 ›
An RSI of 56.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.
CleaRank Financial AI analysis of HRL
The score, the reasoning behind it, and what could move the price next.
Hormel Foods Corporation (HRL) is trending down. The stock is at $20.95, which leaves it 0.61% below its 50-day average of $21.08 and 8.44% below its 200-day average of $22.88. Within its 52-week range, the price is 10.50% above the low of $18.96 and 21.24% below the high of $26.60, so it sits near the bottom of that band. Both averages point the same way, with the 50-day 7.88% below the 200-day.
Recent gains sit against a weaker longer record: the price rose 6.29% over the past month, fell 19.58% over the past three months and fell 12.09% over the past year. The 14-day RSI of 56.7 is in the neutral zone.
Earnings beat ›
The August 27, 2026 report beat the EPS estimate by 5.71%, and the share price rose 1.36% in the first session after it.
Source: Earnings report, August 27, 2026Rating reaffirmed ›
Barclays kept its Overweight rating on October 14, 2026.
Source: Analyst action, Barclays, October 14, 2026
- Keep an eye on the two closest levels: the 50-day SMA at $21.08 sits above the price, while the 20-day EMA at $20.41 sits below it.
- A 14-day RSI of 56.7 lands in the neutral zone. Readings above 70 or below 30 would signal stretched momentum.
HRL sits beneath both its 50-day ($21.08) and 200-day ($22.88) averages, and that placement is why the trend reads down. Reclaiming the 50-day would be the first sign of repair. That average, at $21.08, is the nearest level above the price.
The next marker below the price is the 20-day EMA, at $20.41. The 14-day RSI reads 56.7, which is neutral, sitting between 40 and 60.
Technical indicators
Momentum and trend for HRL, from its daily closes.
As of October 26, 2026, with HRL at $20.95, its 14-day RSI is 56.7 (neutral territory), its 50-day simple moving average is $21.08 and its 200-day is $22.88.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What HRL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, HRL's 1-year correlation of daily returns is +0.00 with S&P 500 (SPY), -0.11 with Nasdaq 100 (QQQ), -0.11 with Bitcoin (BTC) and +0.00 with gold (XAU).
HRL price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
3 of 10 analysts rate it a buy or strong buy, 7 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $25.00 is 19.3% above the price.More buy ratings than three months ago ›
3 of 10 rate it a buy now, against 2 of 10 three months ago.
HRL Wall Street View
12-month price targets
The price, $20.95, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 14, 2026 | Barclays | Maintains | Overweight |
| Oct 7, 2026 | BNP Paribas | Maintains | Neutral |
| Aug 28, 2026 | BNP Paribas | Maintains | Neutral |
| Aug 14, 2026 | JP Morgan | Maintains | Neutral |
| Jul 14, 2026 | BNP Paribas | Maintains | Neutral |
| Jul 9, 2026 | Stephens & Co. | Reiterates | Equal-Weight |
As of October 26, 2026, 10 Wall Street analysts cover HRL: 3 rate it a buy or strong buy, 7 a hold and 0 a sell or strong sell. Their 12-month price targets range from $23.00 to $29.00. The median HRL price target is $25.00, 19.3% above the price of $20.95.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
HRL trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
HRL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from HRL's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much HRL tends to move, against the market and on its own.
HRL price history and drawdowns
HRL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.41% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 58.3%, from April 2022 to October 2026; the price is still 53.7% below that peak.Most 1-year holds ended higher ›
50% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $7,350, against $42,015 in the S&P 500 (SPY).
HRL Drawdowns & Recovery
As of October 26, 2026, HRL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -58.3% (April 2022 to October 2026); it is still 53.7% below that peak, and 50% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into HRL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: HRL trailed the S&P 500 over this period: $7,349.93 against $42,015.
A $10,000 investment in HRL in October 2016 would be worth about $7,350 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to HRL, and which have not.
Strongest month, November: an average of +4.90%, up in 9 of 10 years.
Weakest month, September: an average of -3.03%, up in 3 of 10 years.
This month, October: has averaged -2.16%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, HRL's strongest calendar month has been November (average +4.90%, up in 9 of 10 years) and its weakest September (average -3.03%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
HRL stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in HRL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in HRL today could grow to about $9,894 by 2030 in the base case, with a 90th-percentile outcome near $18,176 and a 10th-percentile outcome around $5,385. The simulation models price only; at today's 5.59% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
HRL Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $20.73 for HRL by 2030 in the base case, from $20.95 today (1.0x over 4 years). The 10th-percentile path ends near $11.28. These are outcomes of a Monte Carlo simulation run on HRL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $15.42 | $20.89 | $28.32 | |
| 2028 | $13.55 | $20.84 | $32.04 | |
| 2029 | $12.27 | $20.78 | $35.19 | |
| 2030 | $11.28 | $20.73 | $38.08 |
Method: a lognormal simulation of HRL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
HRL insider trading
What the people running the company have bought and sold.
HRL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $201K on the open market and sold $817K.
As of October 26, 2026, HRL insiders reported 2 open-market sales worth $817K and 1 open-market purchase worth $201K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | William A Newlands
Chairman of the Board
|
Buy | 10.0K | $201.0K |
| Jul 8, 2026 | Gary C. Bhojwani
Director
|
Sell | 20.2K | $495.2K |
| Jun 9, 2026 | William W. Bonifant
Officer
|
Grant | 5.7K | - |
| Jun 9, 2026 | Domenic Borrelli
Officer
|
Grant | 8.3K | - |
| Apr 14, 2026 | William W. Bonifant
Officer
|
Grant | 12.0K | - |
| Mar 31, 2026 | Gary C. Bhojwani
Director
|
Grant | 2.7K | $60.4K |
| Mar 31, 2026 | William A Newlands
Chairman of the Board
|
Grant | 6.7K | $152.3K |
| Mar 31, 2026 | Christopher J Policinski
Director
|
Grant | 2.5K | $56.4K |
| Mar 31, 2026 | Debbra L.ee Schoneman
Director
|
Grant | 1.3K | $30.2K |
| Mar 31, 2026 | Steven Andrew White
Director
|
Grant | 2.7K | $60.4K |
| Mar 18, 2026 | Steven Andrew White
Director
|
Grant | 5.4K | - |
| Feb 2, 2026 | Scott D Aakre
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | Gary C. Bhojwani
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | John F Ghingo
President
|
Grant | 32.7K | - |
| Feb 2, 2026 | Stephen Mark Lacy
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | Elsa A Murano
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | William A Newlands
Chairman of the Board
|
Grant | 6.5K | - |
| Feb 2, 2026 | Christopher J Policinski
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | Debbra L.ee Schoneman
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | Sally J Smith
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | Steven Andrew White
Director
|
Grant | 6.5K | - |
| Feb 2, 2026 | Michael Paul Zechmeister
Director
|
Grant | 6.5K | - |
| Jan 2, 2026 | Scott D Aakre
Director
|
Grant | 5.6K | - |
| Dec 11, 2025 | Elsa A Murano
Director
|
Sell | 13.4K | $321.6K |
| Dec 9, 2025 | Colleen R Batcheler
Officer
|
Grant | 21.2K | - |
| Dec 9, 2025 | Mary Katherine Clark
Officer
|
Grant | 3.6K | - |
| Dec 9, 2025 | Paul R Kuehneman
Chief Financial Officer
|
Grant | 12.7K | - |
| Dec 9, 2025 | Pierre M Lilly
Officer
|
Grant | 8.5K | - |
| Dec 9, 2025 | Katherine M Losness-Larson
Officer
|
Grant | 8.5K | - |
| Dec 9, 2025 | Kevin L. Myers
Officer
|
Grant | 10.8K | - |
| Dec 9, 2025 | Swen Neufeldt
Officer
|
Grant | 7.6K | - |
| Dec 9, 2025 | David F. Weber
Officer
|
Grant | 5.9K | - |
| Sep 30, 2025 | Gary C. Bhojwani
Director
|
Grant | 2.7K | $65.6K |
| Sep 30, 2025 | William A Newlands
Chairman of the Board
|
Grant | 3.1K | $77.4K |
| Sep 30, 2025 | Christopher J Policinski
Director
|
Grant | 2.3K | $56.4K |
| Sep 30, 2025 | Steven Andrew White
Director
|
Grant | 2.5K | $63.0K |
| Aug 5, 2025 | Scott D Aakre
Director
|
Grant | 7.1K | - |
| Aug 5, 2025 | Jeffrey M Ettinger
Chief Executive Officer
|
Grant | 63.6K | - |
| Aug 5, 2025 | John F Ghingo
President
|
Grant | 4.1K | - |
| Jun 10, 2025 | Kevin L. Myers
Officer
|
Grant | 482 | - |
| Jun 10, 2025 | Swen Neufeldt
Officer
|
Grant | 4.8K | - |
| Jun 10, 2025 | David F. Weber
Officer
|
Grant | 643 | - |
Source: TwelveData, from SEC Form 4 filings
HRL stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.